Cardiology

The American Heart Association and American Stroke Association recently published updated guidelines for the prevention of stroke. Some of the key updates include the utilization of GLP-1 medications and an emphasis on prevention of stroke in women. 

Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death, according to a preliminary study being presented at the American Heart Association's annual Scientific Sessions, set for Nov. 16-18. 

Nearly half of all adults in the U.S. had hypertension between August 2021 and 2023, though men were less likely to be aware of their status.

Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. 22. Of those, 99 hospitals were recognized for delivering superior clinical outcomes in the care and treatment of stroke.

Cleveland Clinic, Chesterfield, Mo.-based Mercy and Bentonville, Ark.-based nonprofit organizations the Alice L. Walton Foundation and the Heartland Whole Health Institute have partnered to invest $700 million over 30 years to address the "$950 million lost annually" as patients leave…

Cleveland Clinic, Chesterfield, Mo.-based Mercy and Bentonville, Ark.-based nonprofit organizations the Alice L. Walton Foundation and the Heartland Whole Health Institute have partnered to invest $700 million over 30 years to address the "$950 million lost annually" as patients leave…

The annual Global Cardio-Oncology Summit was held in September, bringing together healthcare professionals in the context of cardiovascular disease and cancer. 

Greenville, N.C.-based ECU Health's director of cardiovascular disease management services, Stacey Greenway, was appointed president of the American Association of Cardiovascular and Pulmonary Rehabilitation.

A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine. 

A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.